Assessing the effectiveness of treatment by aripiprazole and placebo for control of obsesion in patients with Bipolar mood disorder
Phase 2
- Conditions
- Condition 1: Bipolar disorder. Condition 2: Obsessive-Compulsive disorder.Bipolar affective disorderObsessive-compulsive disorder
- Registration Number
- IRCT2014092719295N1
- Lead Sponsor
- Vice chancellery for Research Shiraz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Inclusion Criteria
Patients with a diagnosis of bipolar disorder according to the DSM IV TR criteria; Yale Brown Score more than 16 at baseline; No important medical condition
Exclusion criteria: Patients were not in acute phase of depression and mania; Important medical condition (cardiovascular, Respirator, renal, Gastrointestinal disease); Pregnancy; Yale Brown Score less than 16 at baseline
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Obsession severity. Timepoint: Weeks 0 and 4 and 8. Method of measurement: Yale Brown Test (Y-BOCS).
- Secondary Outcome Measures
Name Time Method Side edffect. Timepoint: Weeks 4 and 8. Method of measurement: Side effect list.